27 Results

People

  1. Antonescu
    Antonescu
  2. DeMatteo
    DeMatteo
  3. Mauro
    Mauro
  4. Chi
    Chi
  5. Singer
    Singer
  6. Berman
    Berman
  7. Brennan
    Brennan
  8. Dermawan
    Dermawan
  9. Maki
    Maki
  10. Tallman
    Tallman

Groups

  1. Department of Medicine (17)
  2. Hematologic Malignancies, Division of (10)
  3. Center for Hematologic Malignancies (9)
  4. GSK Faculty (9)
  5. Tow Center for Developmental Oncology (TCDO) (9)
  6. Adult Leukemia (8)
  7. Department of Pathology and Laboratory Medicine (8)
  8. Solid Tumor Oncology Division (7)
  9. Surgery (7)
  10. Sarcoma Service (5)
  1. "imatinib mesylate"
Formats
  1. Journal Article (22)
  2. Review (2)
  3. Book Section (1)
  4. Correspondence (1)
  5. Research Letter (1)
Groups
  1. Department of Medicine (17)
  2. Hematologic Malignancies, Division of (10)
  3. Center for Hematologic Malignancies (9)
  4. GSK Faculty (9)
  5. Tow Center for Developmental Oncology (TCDO) (9)
  6. Adult Leukemia (8)

More Groups

People
  1. Cristina Antonescu (7)
  2. Michael Mauro (4)
  3. Ronald DeMatteo (4)
  4. Ping Chi (3)
  5. Samuel Singer (3)
  6. Ellin Berman (2)

More People

Years
  1. 2025 (1)
  2. 2024 (2)
  3. 2023 (3)
  4. 2022 (5)
  5. 2017 (1)
  6. 2016 (1)

More Years

Publications
  1. Cancer (4)
  2. Clinical Cancer Research (3)
  3. Leukemia (3)
  4. Dermatologic Therapy (2)
  5. Journal of Clinical Oncology (2)
  6. Journal of the National Comprehensive Cancer Network (2)

More Publications

Publishers
  1. Nature Publishing Group (6)
  2. Wiley Blackwell (6)
  3. American Association for Cancer Research (3)
  4. Springer (3)
  5. American Society of Clinical Oncology (2)
  6. Biomed Central Ltd (2)

More Publishers

Results (27)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma
    Journal Article

    Kubo, T.; Piperdi, S.; Rosenblum, J.; Antonescu, C. R.; Chen, W.; Kim, H. S.; Huvos, A. G.; Sowers, R.; Meyers, P. A.; Healey, J. H.; more...
    Cancer (2008)

    Fulltext@MSK | Save
  • Outcome of metastatic GIST in the era before tyrosine kinase inhibitors
    Journal Article

    Gold, J. S.; Van Der Zwan, S. M.; Gonen, M.; Maki, R. G.; Singer, S.; Brennan, M. F.; Antonescu, C. R.; DeMatteo, R. P.
    Annals of Surgical Oncology (2007)

    Fulltext@MSK | Save
  • Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma
    Journal Article

    Johnson, F. M.; Krug, L. M.; Tran, H. T.; Shoaf, S.; Prieto, V. G.; Tamboli, P.; Peeples, B.; Patel, J.; Glisson, B. S.
    Cancer (2006)

    Fulltext@MSK | Save
  • Gastrointestinal stromal tumor: 5 years later
    Journal Article

    Van Der Zwan, S. M.; DeMatteo, R. P.
    Cancer (2005)

    Fulltext@MSK | Save
  • Chronic myelogenous leukemia: Clinical practice guidelines in oncology
    Journal Article

    O'Brien, S.; Berman, E.; Bhalla, K.; Copelan, E. A.; Devetten, M. P.; Emanuel, P. D.; Erba, H. P.; Greenberg, P. L.; Moore, J. O.; Przepiorka, D.; more...
    Journal of the National Comprehensive Cancer Network (2005)

    Fulltext@MSK | Save
  • Efficacy of dual-specific Bcr-Abl and Src-family kinase inhibitors in cells sensitive and resistant to imatinib mesylate
    Journal Article

    Tipping, A. J.; Baluch, S.; Barnes, D. J.; Veach, D. R.; Clarkson, B.; Bornmann, W. G.; Mahon, F. X.; Goldman, J. M.; Melo, J. V.
    Leukemia (2004)

    Fulltext@MSK | Save
  • Imatinib mesylate in Philadelphia chromosome-positive leukemia of childhood
    Journal Article

    Kolb, E. A.; Pan, Q.; Ladanyi, M.; Steinherz, P. G.
    Cancer (2003)

    Fulltext@MSK | Save